Developer docs
API playgroundTry for free, no card

Search company profiles

Merito

Full company profile

uuid000j8y8

Namestring
Merito
Legal namestring
Merito K.K.
Websiteurl
merito.network
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Merito K.K. is a Japan-incorporated digital platform company, founded in 2024 and formally established in Fukuoka in March 2025, that connects Japanese deep tech and biomedical researchers with global corporate R&D teams, BioDAOs, and institutional investors. The company digitizes the Sponsored Research Agreement (SRA) workflow — covering discovery, negotiation, e-signature, payment, and ongoing record-keeping — reducing traditional deal timelines from 4–9 months to as little as 3 weeks. Its technology stack combines a web-based project discovery portal, a digital SRA template, and blockchain-based IP-NFT tokenization that enables fractional ownership and programmable revenue sharing via decentralized science (DeSci) infrastructure. The platform is positioned as Japan's primary on-ramp to BioDAO funding communities (VITA DAO, AthenaDAO, ValleyDAO) holding over $2B in aggregate capital.

Merito's business model spans four revenue streams: transaction fees on SRA facilitation between Japanese universities and global pharma/corporate R&D teams, licensing/royalty participation from IP-NFT and DeSci deal structuring, subscription-based investor portal access, and professional services for start-up advisory and curated matchmaking. Pricing is deal-specific rather than standardized, with disclosed project sizes ranging from $120K (Fujislate Cement/Keio) to $200K+ referenced for global corporate partners, well above the $15,000–$25,000 typical of Japanese biopharma sponsorships. The go-to-market is enterprise field sales targeting Japanese universities (Tokyo, Keio, Tsukuba, Kyushu, Nihon) on the supply side and global pharma, BioDAOs, and government agencies on the demand side, supplemented by curated investor trips (e.g., Boston biotech with the Fukuoka Governor's Office) and physical Pop-up Villages (Zō Village, Zō Run Village) that monetize separately as all-inclusive retreats. The company is led by Co-Founder and CEO Brandon Possin, with a Scientific Advisory Council drawn from Takeda Pharma, RIKEN, OIST, SpacePort Japan, and Araya Inc.

Short descriptiontext

Merito is a Japan-incorporated digital platform that connects Japanese university researchers with global corporate R&D teams, BioDAOs, and institutional investors by digitizing Sponsored Research Agreements and tokenizing IP via blockchain, serving Japanese deep tech and biomedical innovators alongside global pharma and crypto-native funders.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersTokyo, Japan
HQ citystring
Tokyo
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sponsored research agreements, research commercialization platform, decentralized science funding, university industry partnerships, deep tech investment advisory
Industry4 codes
PRIMARYFSAPAHAE
Grants, Funding & Budget Allocation Platforms
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSAPAIAC
RWA Tokenization Platforms (asset onboarding, structuring, issuance)
Financial & Insurance/Blockchain & Web3/Enterprise Blockchain & Tokenization (permissioned networks, RWA tokenization)
SECONDARYFSADAMAL
DAO Treasury, Governance & On-Chain Finance Tools
Financial & Insurance/Crypto & Digital Assets/Decentralized Finance (DeFi) Platforms
SECONDARYFSAPAHAD
Coordination & Contributor Management (tasks, bounties, roles)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
NAICS code1 code
  • Financial Transactions Processing, Reserve, and Clearinghouse Activities522320
SIC code1 code
  • Security & Commodity Brokers, Dealers, Exchanges & Services6200
Product category
Research Commercialization Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Sponsored Research Agreement Facilitation
TypeTransaction Fee
Description

Merito facilitates SRAs between Japanese university researchers and global corporate R&D teams. Researchers gain funding from companies and investors; Merito earns a transaction/facilitation fee from orchestrating the deal (SRA negotiation, e-signing, payment execution, and record maintenance).

merito.network
2IP Tokenization / DeSci Deal Fees
TypeLicensing Royalties
Description

For DeSci-funded projects, Merito serves as Japan's portal to science DAOs (BioDAOs) and decentralized investment communities. Revenue derives from structuring and facilitating IP-NFT deals that unlock capital from global crypto-native investors and pharma companies.

merito.network
3Investor Portal Access / Subscription
TypeSubscription Recurring
Description

Merito operates an investor portal where crowd investors access project documentation, scientific white papers, and contribute to Special Purpose Vehicles (SPVs) supporting research IP. The platform enables direct engagement with researchers and distribution of licensing revenue on exit.

merito.network
4Start-up Advisory and Business Matching
TypeProfessional Services
Description

Merito provides curated matchmaking and fundraising advisory to Japanese deep tech start-ups, connecting them with R&D and venture capital partners. The Fukuoka Governor's Office and university spinoffs are specific examples of this advisory revenue stream.

merito.network
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1Zō Village: Myoko, Japan (August 2026) — $800/week or $2,000/month pass (plus room supplement), all-inclusive
ModelSubscriptionBilling cadenceMonthly
Notes

All-inclusive pricing covers accommodation, three chef-prepared meals daily, gym access, daily classes, workshops on AI/Web3/bio-hacking, and curated community programming. Room supplement is additional.

merito.network
2Zō Run Village: Kawisari Coffee Plantation, East Java, Indonesia (October 2026) — $350 Early Bird (all-inclusive)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

All-inclusive pricing covers accommodation at historic heritage site, all meals, guided trail runs through coffee groves at 1,000m elevation, and community programming. Early Bird rate available.

merito.network
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Merito operates a digital platform that connects Japanese university researchers and deep tech startups with global corporate R&D teams, investors, and DeSci funding communities. Its core service is facilitating Sponsored Research Agreements (SRAs) end-to-end — from project discovery and negotiation through e-signing, payment execution, and record maintenance — reducing traditional deal timelines from 4–9 months to as little as 3 weeks. The platform integrates blockchain-based IP tokenization (IP-NFTs) and DAO governance to enable fractional ownership and programmable revenue sharing for research IP.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • SRA deal time reduced from 4–9 months (traditional) to as little as 3 weeks on Merito's platform
+5 more records
Product overview1 text field

Merito is a digital platform connecting Japan-based deep tech innovators with global capital, consisting of the Merito Network Platform for deal-making and research funding, Pop-up Villages (curated physical retreat communities), and advisory/matching services. The platform enables Sponsored Research Agreements (SRAs) between researchers and investors/corporate R&D teams. Featured projects include Fujislate Cement (sustainable cement production at Keio University), Attune (capillary structure analysis at University of Tokyo), and Fukuoka Governor's Office advisory work connecting Japanese biotech ventures with U.S. investors.

Product and service4 records
1Merito Network Platform
2Pop-up Villages
CategoryCurated Retreat Community
Description

Curated temporary community retreats designed to remove daily logistics and enable focus on deep work, physical vitality, and human connection. Includes Zō Village (Myoko, Japan) and Zō Run Village (East Java, Indonesia), featuring accommodation, chef-prepared meals, daily classes, workshops on AI/Web3/bio-hacking, and community programming.

3Start-up Advisory
CategoryAdvisory and Consulting Service
Description

Advisory service that boosts a start-up's growth potential and prepares it for global growth and fundraising. Merito works closely with founders to scale their ventures and connect with funding opportunities.

4Curated Matchmaking
CategoryInvestor Matchmaking Service
Description

Tailor-made funding solutions connecting Japanese deep tech innovators with R&D and venture capital partners for traditional financing needs. Provides curated introductions and structured deal-making for startups preferring conventional funding routes.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-03-12
Description

Kyoto Fusioneering signed a research agreement on plasma heating with the University of Tsukuba, facilitated through open innovation networks. Merito connects similar Japanese science teams with corporate and international partners for joint R&D agreements.

2Teijin Pharma
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Teijin Pharma invested in Jiksak Bioengineering through a joint research agreement to identify novel drug target genes for neurodegenerative diseases, demonstrating the open innovation model Merito facilitates between Japanese pharma and biotech startups.

merito.network
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SoftBank partnered with the University of Tokyo to form the Beyond AI institute, translating basic and applied AI research for industrial uses. Merito positions itself as a platform that can facilitate similar university-industry partnerships at scale.

4Nikon
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nikon has an array of open innovation funding relationships with University of Tokyo, Osaka University, and Kyoto University. Nikon has also partnered with SBI Bank via the Nikon SBI Innovation Fund to support science funding. Nikon's open innovation model exemplifies the type of partnerships Merito aims to facilitate more broadly.

merito.network
5Fukuoka Governor's Office
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Fukuoka Governor's Office hired Merito to make introductions to 11 U.S. biotech investors for five Fukuoka biotech ventures and to plan investment-focused trips to Boston. Merito supported two U.S.-based investment fundraising campaigns for nine Fukuoka biotech start-ups.

merito.network
Strategic tierMinorTypeStrategic or Co-development Partner
Description

BioLabs is a co-working laboratory network that has opened facilities in Kawasaki and Tsukuba, Japan, with a new OpenLab planned for Fukuoka in 2025 by Fukuoka Jisho. Merito enables independent Japanese scientists to research in OpenLabs, linking its researcher network with physical lab infrastructure.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

U.S.-based Altos Labs funded Kyoto University scientists (notably Nobel laureate Dr. Yamanaka's associates at CIRA). This demonstrates the rare but significant case of foreign investment in Japanese science that Merito aims to make more common.

Strategic tierCoreTypeTechnology or Integration
Description

DeSci World builds Proof of Knowledge products and DeSci Nodes — an open-science solution for researchers to publish and manage manuscripts, data, code, and digital research objects. Merito's platform integrates with or leverages similar DeSci infrastructure for blockchain-based IP tokenization.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Molecule is the most direct peer: a Web3 platform for IP-NFTs and decentralized funding of early-stage scientific research. Like Merito, it enables tokenization of research IP and connects scientists with global capital via DeSci rails; Merito differentiates by being Japan-focused and adding an SRA facilitation layer.

TypeDirect peer
Description

VitaDAO is one of the largest BioDAOs funding longevity research through token-governed IP-NFTs and has partnered with Pfizer. It is a direct comparable as both a BioDAO partner and a competing source of capital/deal flow for research projects Merito is trying to route through Japan.

TypeDirect peer
Description

ResearchHub is a web platform that connects researchers and rewards scientific contribution with crypto tokens. It is comparable as a DeSci-adjacent platform facilitating open research collaboration and reward flows, though with a publication/open-science orientation rather than Merito's SRA/IP-tokenization focus.

TypeEmerging player
Description

ValleyDAO is a BioDAO funding synthetic biology research through tokenized IP-NFTs. It is comparable as a listed Merito distribution partner and a parallel DeSci funding community operating in the same tokenized-research model.

TypeBroad incumbent
Description

Inpart is an established digital platform matching academic IP with corporate R&D teams, with a broad pharma and deep-tech customer base. It is comparable as the conventional, non-DeSci incumbent Merito is disrupting for Japan-to-global research deal flow.

TypeDirect peer
Description

LabDAO is a decentralized community coordinating wet-lab research and IP via tokenized contributions. It is comparable as a DeSci platform working to tokenize and coordinate scientific work, and intersects with Merito's IP-NFT and researcher-coordination model.

TypeEmerging player
Description

AthenaDAO is a BioDAO funding women's reproductive health research via IP-NFTs and DAO governance. It is comparable as a listed Merito distribution partner and a parallel DeSci capital pool targeting specific research verticals.

TypeDirect peer
Description

Bio.xyz (Bio Protocol) is a BioDAO launchpad and DeSci infrastructure layer that incubates and funds decentralized science communities. It is comparable as both DeSci infrastructure Merito integrates with and as a competing platform for spinning up and funding research DAOs.

TypeEmerging player
Description

CryoDAO is a BioDAO funding cryopreservation and longevity research through IP-NFTs and DAO governance. It is comparable as a DeSci capital pool operating on the same IP-NFT/DAO rails that Merito channels Japanese researchers toward.

TypeOthers
Description

DeSci Foundation is an ecosystem- and standards-oriented organization promoting decentralized science globally. It is comparable as the broader DeSci ecosystem context in which Merito operates and from which it sources community and capital.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Merito

Research Commercialization Servicesmerito.network

Merito is a Japan-incorporated digital platform that connects Japanese university researchers with global corporate R&D teams, BioDAOs, and institutional investors by digitizing Sponsored Research Agreements and tokenizing IP via blockchain, serving Japanese deep tech and biomedical innovators alongside global pharma and crypto-native funders.

What Merito does

Merito K.K. is a Japan-incorporated digital platform company, founded in 2024 and formally established in Fukuoka in March 2025, that connects Japanese deep tech and biomedical researchers with global corporate R&D teams, BioDAOs, and institutional investors. The company digitizes the Sponsored Research Agreement (SRA) workflow — covering discovery, negotiation, e-signature, payment, and ongoing record-keeping — reducing traditional deal timelines from 4–9 months to as little as 3 weeks. Its technology stack combines a web-based project discovery portal, a digital SRA template, and blockchain-based IP-NFT tokenization that enables fractional ownership and programmable revenue sharing via decentralized science (DeSci) infrastructure. The platform is positioned as Japan's primary on-ramp to BioDAO funding communities (VITA DAO, AthenaDAO, ValleyDAO) holding over $2B in aggregate capital.

Merito's business model spans four revenue streams: transaction fees on SRA facilitation between Japanese universities and global pharma/corporate R&D teams, licensing/royalty participation from IP-NFT and DeSci deal structuring, subscription-based investor portal access, and professional services for start-up advisory and curated matchmaking. Pricing is deal-specific rather than standardized, with disclosed project sizes ranging from $120K (Fujislate Cement/Keio) to $200K+ referenced for global corporate partners, well above the $15,000–$25,000 typical of Japanese biopharma sponsorships. The go-to-market is enterprise field sales targeting Japanese universities (Tokyo, Keio, Tsukuba, Kyushu, Nihon) on the supply side and global pharma, BioDAOs, and government agencies on the demand side, supplemented by curated investor trips (e.g., Boston biotech with the Fukuoka Governor's Office) and physical Pop-up Villages (Zō Village, Zō Run Village) that monetize separately as all-inclusive retreats. The company is led by Co-Founder and CEO Brandon Possin, with a Scientific Advisory Council drawn from Takeda Pharma, RIKEN, OIST, SpacePort Japan, and Araya Inc.

Merito firmographics

Firmographics
Name
Merito
Legal name
Merito K.K.
Website
https://merito.network
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
Merito is a Japan-incorporated digital platform that connects Japanese university researchers with global corporate R&D teams, BioDAOs, and institutional investors by digitizing Sponsored Research Agreements and tokenizing IP via blockchain, serving Japanese deep tech and biomedical innovators alongside global pharma and crypto-native funders.
Ownership category
akta.pro rank

Merito industry classification

Industry
Product category
Research Commercialization Services
NAICS
Financial Transactions Processing, Reserve, and Clearinghouse Activities (522320)
SIC
Security & Commodity Brokers, Dealers, Exchanges & Services (6200)
akta.pro industry
PRIMARYFSAPAHAE
Grants, Funding & Budget Allocation Platforms
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSAPAIAC
RWA Tokenization Platforms (asset onboarding, structuring, issuance)
Financial & Insurance/Blockchain & Web3/Enterprise Blockchain & Tokenization (permissioned networks, RWA tokenization)
SECONDARYFSADAMAL
DAO Treasury, Governance & On-Chain Finance Tools
Financial & Insurance/Crypto & Digital Assets/Decentralized Finance (DeFi) Platforms
SECONDARYFSAPAHAD
Coordination & Contributor Management (tasks, bounties, roles)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)

Keywords

  • Sponsored research agreements
  • Research commercialization platform
  • Decentralized science funding
  • University industry partnerships
  • Deep tech investment advisory

Where Merito is headquartered

Location

Headquarters

HQ city
Tokyo
HQ country
Japan
HQ region
Asia

Offices2 records

Markets served

Merito business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Sponsored Research Agreement Facilitation: Merito facilitates SRAs between Japanese university researchers and global corporate R&D teams. Researchers gain funding from companies and investors; Merito earns a transaction/facilitation fee from orchestrating the deal (SRA negotiation, e-signing, payment execution, and record maintenance).
  2. IP Tokenization / DeSci Deal Fees: For DeSci-funded projects, Merito serves as Japan's portal to science DAOs (BioDAOs) and decentralized investment communities. Revenue derives from structuring and facilitating IP-NFT deals that unlock capital from global crypto-native investors and pharma companies.
  3. Investor Portal Access / Subscription: Merito operates an investor portal where crowd investors access project documentation, scientific white papers, and contribute to Special Purpose Vehicles (SPVs) supporting research IP. The platform enables direct engagement with researchers and distribution of licensing revenue on exit.
  4. Start-up Advisory and Business Matching: Merito provides curated matchmaking and fundraising advisory to Japanese deep tech start-ups, connecting them with R&D and venture capital partners. The Fukuoka Governor's Office and university spinoffs are specific examples of this advisory revenue stream.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyZō Village: Myoko, Japan (August 2026) — $800/week or $2,000/month pass (plus room supplement), all-inclusive
One time/ perpetual licensePay-as-you-goZō Run Village: Kawisari Coffee Plantation, East Java, Indonesia (October 2026) — $350 Early Bird (all-inclusive)

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Merito product offering

Product offering

Core offering

Merito operates a digital platform that connects Japanese university researchers and deep tech startups with global corporate R&D teams, investors, and DeSci funding communities. Its core service is facilitating Sponsored Research Agreements (SRAs) end-to-end — from project discovery and negotiation through e-signing, payment execution, and record maintenance — reducing traditional deal timelines from 4–9 months to as little as 3 weeks. The platform integrates blockchain-based IP tokenization (IP-NFTs) and DAO governance to enable fractional ownership and programmable revenue sharing for research IP.

Product overview

Merito is a digital platform connecting Japan-based deep tech innovators with global capital, consisting of the Merito Network Platform for deal-making and research funding, Pop-up Villages (curated physical retreat communities), and advisory/matching services. The platform enables Sponsored Research Agreements (SRAs) between researchers and investors/corporate R&D teams. Featured projects include Fujislate Cement (sustainable cement production at Keio University), Attune (capillary structure analysis at University of Tokyo), and Fukuoka Governor's Office advisory work connecting Japanese biotech ventures with U.S. investors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Merito Network Platform
  • Pop-up Villages Curated temporary community retreats designed to remove daily logistics and enable focus on deep work, physical vitality, and human connection. Includes Zō Village (Myoko, Japan) and Zō Run Village (East Java, Indonesia), featuring accommodation, chef-prepared meals, daily classes, workshops on AI/Web3/bio-hacking, and community programming.
  • Start-up Advisory Advisory service that boosts a start-up's growth potential and prepares it for global growth and fundraising. Merito works closely with founders to scale their ventures and connect with funding opportunities.
  • Curated Matchmaking Tailor-made funding solutions connecting Japanese deep tech innovators with R&D and venture capital partners for traditional financing needs. Provides curated introductions and structured deal-making for startups preferring conventional funding routes.

Quantifiable outcome

  • SRA deal time reduced from 4–9 months (traditional) to as little as 3 weeks on Merito's platform
  • +5 more outcomes

Companies that use Merito

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles5 records

Merito technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Merito partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor and core.

  • Kyoto FusioneeringminorStrategic or Co-development Partner · 12 March 2024Kyoto Fusioneering signed a research agreement on plasma heating with the University of Tsukuba, facilitated through open innovation networks. Merito connects similar Japanese science teams with corporate and international partners for joint R&D agreements.
  • Teijin PharmacoreStrategic or Co-development PartnerTeijin Pharma invested in Jiksak Bioengineering through a joint research agreement to identify novel drug target genes for neurodegenerative diseases, demonstrating the open innovation model Merito facilitates between Japanese pharma and biotech startups.
  • SoftBank / Beyond AI Institute (University of Tokyo)coreStrategic or Co-development PartnerSoftBank partnered with the University of Tokyo to form the Beyond AI institute, translating basic and applied AI research for industrial uses. Merito positions itself as a platform that can facilitate similar university-industry partnerships at scale.
  • NikoncoreStrategic or Co-development PartnerNikon has an array of open innovation funding relationships with University of Tokyo, Osaka University, and Kyoto University. Nikon has also partnered with SBI Bank via the Nikon SBI Innovation Fund to support science funding. Nikon's open innovation model exemplifies the type of partnerships Merito aims to facilitate more broadly.
  • Fukuoka Governor's OfficecoreStrategic or Co-development PartnerThe Fukuoka Governor's Office hired Merito to make introductions to 11 U.S. biotech investors for five Fukuoka biotech ventures and to plan investment-focused trips to Boston. Merito supported two U.S.-based investment fundraising campaigns for nine Fukuoka biotech start-ups.
  • BioLabsminorStrategic or Co-development PartnerBioLabs is a co-working laboratory network that has opened facilities in Kawasaki and Tsukuba, Japan, with a new OpenLab planned for Fukuoka in 2025 by Fukuoka Jisho. Merito enables independent Japanese scientists to research in OpenLabs, linking its researcher network with physical lab infrastructure.
  • Altos LabsminorStrategic or Co-development PartnerU.S.-based Altos Labs funded Kyoto University scientists (notably Nobel laureate Dr. Yamanaka's associates at CIRA). This demonstrates the rare but significant case of foreign investment in Japanese science that Merito aims to make more common.
  • DeSci WorldcoreTechnology or IntegrationDeSci World builds Proof of Knowledge products and DeSci Nodes — an open-science solution for researchers to publish and manage manuscripts, data, code, and digital research objects. Merito's platform integrates with or leverages similar DeSci infrastructure for blockchain-based IP tokenization.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Merito competitors and assessment

Company assessment

Direct peers

  • Molecule: Molecule is the most direct peer: a Web3 platform for IP-NFTs and decentralized funding of early-stage scientific research. Like Merito, it enables tokenization of research IP and connects scientists with global capital via DeSci rails; Merito differentiates by being Japan-focused and adding an SRA facilitation layer.
  • VitaDAO: VitaDAO is one of the largest BioDAOs funding longevity research through token-governed IP-NFTs and has partnered with Pfizer. It is a direct comparable as both a BioDAO partner and a competing source of capital/deal flow for research projects Merito is trying to route through Japan.
  • ResearchHub: ResearchHub is a web platform that connects researchers and rewards scientific contribution with crypto tokens. It is comparable as a DeSci-adjacent platform facilitating open research collaboration and reward flows, though with a publication/open-science orientation rather than Merito's SRA/IP-tokenization focus.
  • LabDAO: LabDAO is a decentralized community coordinating wet-lab research and IP via tokenized contributions. It is comparable as a DeSci platform working to tokenize and coordinate scientific work, and intersects with Merito's IP-NFT and researcher-coordination model.
  • Bio Protocol: Bio.xyz (Bio Protocol) is a BioDAO launchpad and DeSci infrastructure layer that incubates and funds decentralized science communities. It is comparable as both DeSci infrastructure Merito integrates with and as a competing platform for spinning up and funding research DAOs.

Emerging players

  • ValleyDAO: ValleyDAO is a BioDAO funding synthetic biology research through tokenized IP-NFTs. It is comparable as a listed Merito distribution partner and a parallel DeSci funding community operating in the same tokenized-research model.
  • AthenaDAO: AthenaDAO is a BioDAO funding women's reproductive health research via IP-NFTs and DAO governance. It is comparable as a listed Merito distribution partner and a parallel DeSci capital pool targeting specific research verticals.
  • CryoDAO: CryoDAO is a BioDAO funding cryopreservation and longevity research through IP-NFTs and DAO governance. It is comparable as a DeSci capital pool operating on the same IP-NFT/DAO rails that Merito channels Japanese researchers toward.

Broad incumbents

  • Inpart: Inpart is an established digital platform matching academic IP with corporate R&D teams, with a broad pharma and deep-tech customer base. It is comparable as the conventional, non-DeSci incumbent Merito is disrupting for Japan-to-global research deal flow.

Others

  • DeSci Foundation: DeSci Foundation is an ecosystem- and standards-oriented organization promoting decentralized science globally. It is comparable as the broader DeSci ecosystem context in which Merito operates and from which it sources community and capital.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Merito social profiles

Digital presence

Merito financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Merito leadership team

Management profile

Number of profiles

Profiles10 records

Merito funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Merito M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Merito

What does Merito do?

Merito operates a digital platform that connects Japanese university researchers and deep tech startups with global corporate R&D teams, investors, and DeSci funding communities. Its core service is facilitating Sponsored Research Agreements (SRAs) end-to-end — from project discovery and negotiation through e-signing, payment execution, and record maintenance — reducing traditional deal timelines from 4–9 months to as little as 3 weeks. The platform integrates blockchain-based IP tokenization (IP-NFTs) and DAO governance to enable fractional ownership and programmable revenue sharing for research IP.

Is Merito a public or private company?

Merito is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Merito founded?

Merito was founded in 2025. It employs 1 to 10 people.

Where is Merito based?

Merito is headquartered in Tokyo, Japan, in the Asia region.

How does Merito make money?

Four revenue lines are on record. Sponsored Research Agreement Facilitation is the primary driver. The others are IP Tokenization / DeSci Deal Fees, investor Portal Access / Subscription and start-up Advisory and Business Matching.

Who are Merito's main competitors?

Direct peers on record are Molecule, VitaDAO, ResearchHub, LabDAO and Bio Protocol. Emerging players are ValleyDAO, AthenaDAO and CryoDAO. Inpart is listed as a broad incumbent. DeSci Foundation is listed as an others.

Does Merito have an API?

No public API is recorded for Merito.

What industry is Merito in?

Merito's product category is Research Commercialization Services. Its primary akta.pro industry code is FSAPAHAE, Grants, Funding & Budget Allocation Platforms, with a secondary code of FSAPAIAC, RWA Tokenization Platforms (asset onboarding, structuring, issuance). Its NAICS code is 522320 and its SIC code is 6200.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales